Jazz Pharmaceuticals Competitors and Similar CompaniesClear all
Jazz Pharmaceuticals's competitors and similar companies include UCB and Kyverna Therapeutics.
 Jazz Pharmaceuticals Jazz Pharmaceuticals is a biopharmaceutical company engaged in developing and marketing medicines for sleep disorders, epilepsy, and oncology. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Kyverna Therapeutics Kyverna Therapeutics is a pharmaceutical company that generates treatments and potential cures for autoimmune diseases. | |
Founding Date | Founding Date 2003 | Founding Date 1928 | Founding Date 2018 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Dublin, IE HQ Mississauga, CA Vancouver, CA Lyon, FR München, DE Roscommon, IE Villa Guardia, IT see more | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations Emeryville, US HQ |
Employees | Employees 2,800 | Employees 9,052 | Employees 84 |
Valuation ($) | Valuation ($) 6.9 b | Valuation ($) 34.3 b | Valuation ($) 230.8 m |
Financial | |||
Revenue (est.) | Revenue (est.) $4.3b (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($356.1m) (FY, 2025) | Net income €1.6b (FY, 2025) | Net income ($161.3m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 384.1m | Total funding raised N/A | Total funding raised $ 25m |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyKyverna Therapeutics
HQ
Emeryville, US
Employees
84
Kyverna Therapeutics is a pharmaceutical company that generates treatments and potential cures for autoimmune diseases.
View company